Stay updated on Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial
Sign up to get notified when there's something new on the Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial page.

Latest updates to the Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe update appears to consist of minor UI refinements and layout adjustments, with no changes to core study content. Core details such as eligibility criteria, outcomes, and enrollment remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check15 days agoNo Change Detected
- Check38 days agoChange DetectedVersion update from v3.0.2 to v3.2.0 indicating a new release; no other content changes detected.SummaryDifference0.1%

- Check39 days agoChange DetectedUpdates the revision tag from v3.0.2 to v3.1.0, indicating a new release version without substantive changes to visible content.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page now shows revision v3.0.2, indicating a new release. The 'Back to Top' link was removed; aside from the version bump, there are no other substantive changes to pricing, stock, or time-related information.SummaryDifference0.3%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.3%

- Check68 days agoChange DetectedThe web page has updated its facility name and location details, specifically clarifying the location to South Korea, Gyeonggi-do, Seongnam-si, while removing previous location terms and references to vaccines.SummaryDifference2%

Stay in the know with updates to Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial page.